First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S NEW BRUNSWICK, NJ – Johnson & Johnson (NYSE:… Read More
Vancouver, BC – September 22, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and… Read More
SAN DIEGO, Sept. 21, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced its financial… Read More
Interim data suggests that LY-CoV555 has a direct antiviral effect and may reduce COVID-related hospitalizations VANCOUVER, British Columbia, September 16, 2020 – AbCellera today announced that interim data from a… Read More
VANCOUVER, BC – September 16, 2020 – LifeSciences BC is pleased to recognize the recipients of the 22nd Annual LifeSciences BC Awards, presented by FARRIS, at our awards event online,… Read More
